TP53 and B-cell chronic lymphocytic leukemia: CLL cells that express high levels of ROR1 also are noted more commonly to express unmutated IGHV, have complex karyotypes, and/or inactivating mutations in TP53 than CLL cells with low-ROR1 [24].